Skip to main content
. 2019 Apr;11(Suppl 6):S902–S912. doi: 10.21037/jtd.2018.11.116

Table 4. Intraoperative data.

Characteristics Total Group 1, TR 0–1 Group 2, TR 2–3 P value Group 2a, non-TVR Group 2b, TVR P value
Durations, min
   Operation 236.2±84.5 220.2±72.7 275.1±98.3 0.002 230.4±101.4 319.7±73.3 0.001
   Cardiopulmonary bypass 117.2±51.1 104.8±41.6 146.0±59.5 <0.001 127.3±71.2 163.6±40.6 0.002
LVAD model, n (%)
   HeartMate II 74 (59.7) 49 (55.77) 25 (69.4) 0.11 14 (77.8) 11 (61.1) 0.47
   HeartWare 16 (12.9) 12 (13.6) 4 (11.1) 0.48 2 (11.1) 2 (11.1) 0.67
   HeartMate III 34 (27.4) 27 (30.7) 7 (19.4) 0.15 2 (11.1) 5 (27.8) 0.2
Concomitant procedures (also in various combinations), n (%)
   Aortic valve replacement 11 (8.9) 6 (6.8) 5 (13.9) 0.18 3 (16.7) 2 (11.1) 0.5
   Coronary artery bypass graft 5 (4.0) 2 (2.3) 3 (8.3) 0.15 3 (16.7) 0 (0) 0.23
   Atrium septum defect closure 14 (11.3) 11 (12.5) 3 (8.3) 0.38 2 (11.1) 1 (5.6) 0.5
   Atrium ablation 2 (1.6) 0 (0) 2 (5.6) 0.08 2 (11.1) 0 (0) 0.24
   Left atrial appendage closure 7 (5.6) 2 (2.3) 5 (13.9) 0.02 3 (16.7) 2 (11.1) 0.5
   Ventricular septum defect closure 2 (1.6) 1 (1.1) 1 (2.8) 0.49 0 (0) 1 (5.6) 0.5
Other characteristics, n (%)
   Plegia 24 (19.4) 12 (13.6) 12 (33.3) 0.01 6 (33.3) 6 (33.3) 0.64
   ST-RVAD, intraoperative implantation 15 (12.1) 7 (8.0) 8 (22.2) 0.03 3 (16.7) 5 (27.8) 0.35
   Open chest after surgery because of haemodynamic instability 12 (9.7) 8 (9.1) 4 (11.1) 0.49 0 (0) 4 (22.2) 0.05

TR, tricuspid regurgitation; TVR, tricuspid valve reconstruction; LVAD, left ventricular assist device; ST-RVAD, short-term right ventricular assist device.